No Data
No Data
Express News | Kineta Shares Are Trading Higher After the Company Announced It Reopened Patient Enrollment for Its VISTA-101 Clinical Trial
Express News | Kineta Reopens Enrollment For Its Oncoinc VISTA-101 Clinical Trial Evaluating KVA12123 In Advanced Solid Tumor Cancer
Express News | Kineta Inc - Anticipates Trial to Be Fully Enrolled by End of 2024
Express News | Kineta Reopens Enrollment for the Vista-101 Clinical Trial Evaluating Kva12123 in Patients With Advanced Solid Tumor Cancer
Kineta | 10-Q: Q2 2024 Earnings Report
Kineta Enters Into $5 Million Agreement With TuHURA Biosciences for Vista Blocking Immunotherapy; Shares Rise
No Data